Cover image of the article: The Enhancing Effect of Sodium Glycocholate and Sodium Salicylate on Rats     Gastro-intestinal Permeability to Insulin

Image Credit:Iran J Pharm Res

The Enhancing Effect of Sodium Glycocholate and Sodium Salicylate on Rats Gastro-intestinal Permeability to Insulin

Authors

Eskandar MoghimipourEskandar Moghimipour ORCID1,*, Amir Jalali2, Seyyed Abolghassem Sajjadi Tabassi3, Raimar Löbenberg4
1Department of Pharmaceutics, School of Pharmacy, Jondishapour University of Medical Sciences, Ahwaz, Iran
2Department of Pharmacologys, School of Pharmacy, Shaheed Beheshti University of Medical Sciences, Tehran, Iran
3Department of Pharmaceutics, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
4Faculty of Pharmacy and Pharmaceutical Science, Dentistry/Pharmacy Centre, University of Alberta, Edmonton, Alberta, Canada
*Corresponding Author: Department of Pharmaceutics, School of Pharmacy, Jondishapour University of Medical Sciences, Ahwaz, Iran. Email:moghimipour@yahoo.com

Iranian Journal of Pharmaceutical Research:Vol. 3, issue 2; 87-91
Published online:Nov 20, 2010
Article type:Research Article
Received:Jan 01, 2004
Accepted:Jul 01, 2004
How to Cite:Moghimipour E, Jalali A, Sajjadi Tabassi SA, Löbenberg R. The Enhancing Effect of Sodium Glycocholate and Sodium Salicylate on Rats Gastro-intestinal Permeability to Insulin. Iran J Pharm Res. 2022;3(2):e128187. doi: https://doi.org/10.22037/ijpr.2010.581

Abstract

There have been numerous efforts to formulate insulin into an oral dosage form. The major problems involved with the oral administration of insulin are acidic and enzymatic decomposition by the gastric medium, and poor absorption in the small intestine due to its macromolecular structure.

This study attempted to test the enhancing ability of two absorption enhancers, sodium glycocholate (Na-GC) and sodium salicylate (Na-Sal), in different parts of rat's gastro-intestinal tract. The amount of insulin in each formulation was 0.6 iu/kg body weight. The concentration of enhancers (Na-Sal or Na-GC) in each formulation was 10 µg/ml. Formulations made of insulin and enhancers were prepared and injected directly to stomach, duodenum, jejunum and ileum of anesthetized rats through an abdominal incision. Blood samples were taken at 45 and 60 min intervals. The glucose concentration was determined by the o-toluidine method. Injections (IP) of insulin and normal saline were positive and negative controls, respectively.

The blood glucose concentrations showed a significant decrease (p<0.05) due to the injection of insulin into duodenum, while the effect noted in jejunum was insignificant (p>0.05). Also, there was no anti-hyperglycemic effect accompanied by formulations administered into the stomach and ileum. It could be concluded that insulin, if formulated in a protected form to prevent acidic and enzymatic decomposition, in combination with such enhancers may overcome hyperglycemia due to insulin deficiency.

Highlights

Copyright

© 2022, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

20
Nov
2010
Invitro Release Study of Sodium Salicylate from Lecithin Based Phospholipid Microemulsions

Invitro Release Study of Sodium Salicylate from Lecithin Based Phospholipid Microemulsions

Reza Aboofazeli,
Seyed Alireza Mortazavi,
Pooneh Khoshnevis

Aboofazeli R, Mortazavi SA, Khoshnevis P. Invitro Release Study of Sodium Salicylate from Lecithin Based Phospholipid Microemulsions. Iran J Pharm Res. 2022;2(2):e127618. doi: https://doi.org/10.22037/ijpr.2010.19

31
Jan
2010
Formulation and In Vitro Characterization of Xanthan Gum-Based Sustained Release Matrix Tables of Isosorbide-5- Mononitrate

Formulation and In Vitro Characterization of Xanthan Gum-Based Sustained Release Matrix Tables of Isosorbide-5- Mononitrate

Rajat Kar,
Snehamayee Mohapatra,
Satyabrata Bhanja,
Debjyoti Das,
Bhaktibhusan Barik

Kar R, Mohapatra S, Bhanja S, Das D, Barik B. Formulation and In Vitro Characterization of Xanthan Gum-Based Sustained Release Matrix Tables of Isosorbide-5- Mononitrate. Iran J Pharm Res. 2010;9(1):e126039. doi: https://doi.org/10.22037/ijpr.2010.830

31
Jan
2011
Characterization of Olanzapine-Solid Dispersions

Characterization of Olanzapine-Solid Dispersions

Venkateskumar Krishnamoorthy,
Arunkumar Nagalingam,
Verma Priya Ranjan Prasad,
Siva Parameshwaran,
Neema George,
Punitha Kaliyan

Krishnamoorthy V, Nagalingam A, Priya Ranjan Prasad V, Parameshwaran S, George N, et al. Characterization of Olanzapine-Solid Dispersions. Iran J Pharm Res. 2011;10(1):e125925. doi: https://doi.org/10.22037/ijpr.2010.880

31
Jul
2015
Design and Comparative Evaluation of In-vitro Drug Release, Pharmacokinetics and Gamma Scintigraphic Analysis of Controlled Release Tablets Using Novel pH Sensitive Starch and Modified Starch- acrylate Graft Copolymer Matrices

Design and Comparative Evaluation of In-vitro Drug Release, Pharmacokinetics and Gamma Scintigraphic Analysis of Controlled Release Tablets Using Novel pH Sensitive Starch and Modified Starch- acrylate Graft Copolymer Matrices

Pankaj Kumar,
Ashok Laxmanrao Ganure,
Bharat Bhushan Subudhi,
Shubhanjali Shukla

Kumar P, Ganure AL, Subudhi BB, Shukla S. Design and Comparative Evaluation of In-vitro Drug Release, Pharmacokinetics and Gamma Scintigraphic Analysis of Controlled Release Tablets Using Novel pH Sensitive Starch and Modified Starch- acrylate Graft Copolymer Matrices. Iran J Pharm Res. 2015;14(3):e125329. doi: https://doi.org/10.22037/ijpr.2015.1700

20
Aug
2023
Oral Delivery of Insulin from Trimethyl Chitosan/Tragacanth: In Vitro, MTT, and In Vivo Bioactivity Tests

Oral Delivery of Insulin from Trimethyl Chitosan/Tragacanth: In Vitro, MTT, and In Vivo Bioactivity Tests

Alireza Khajeh-Amiri,
Ali Maghsoudi

Khajeh-Amiri A, Maghsoudi A. Oral Delivery of Insulin from Trimethyl Chitosan/Tragacanth: In Vitro, MTT, and In Vivo Bioactivity Tests. Ann Mil Health Sci Res. 2023;21(1):e137796. doi: https://doi.org/10.5812/amh-137796

More by these authors

Eskandar MoghimipourPubMedScholar
Amir JalaliPubMedScholar
Seyyed Abolghassem Sajjadi TabassiPubMedScholar
Raimar LöbenbergPubMedScholar
Share
Cited by
Metrics